CAT-Abbott settles on morning of appeal
The IP dispute between Cambridge Antibody Technology (CAT) and Abbott Laboratories has reached a shock settlement ahead of a Court of Appeal hearing due to start today (26 October). Freshfields Bruckhaus Deringer client Abbott had appealed a December 2004 decision of Mr Justice Laddie over the royalties payable over CAT’s ground breaking rheumatoid arthritis drug […]